Forte Biosciences, Inc. - stock earnings
FBRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -10.0 million USD | ? USD |
| 2023Q2 | -8.9 million USD | ? USD |
| 2023Q1 | -6.7 million USD | ? USD |
| 2022Q4 | -4.9 million USD | ? USD |
| 2022Q3 | -3.4 million USD | ? USD |
| 2022Q2 | -3.1 million USD | ? USD |
| 2022Q1 | -2.6 million USD | ? USD |
| 2021Q4 | -3.3 million USD | ? USD |
| 2021Q3 | -7.8 million USD | ? USD |
| 2021Q2 | -5.8 million USD | ? USD |
| 2021Q1 | -4.8 million USD | ? USD |
| 2020Q4 | -4.6 million USD | ? USD |
| 2020Q3 | -5.1 million USD | ? USD |
| 2020Q2 | -34.8 million USD | ? USD |
| 2020Q1 | -2.1 million USD | 9000 USD |
| 2019Q4 | -10.6 million USD | 9000 USD |
| 2019Q3 | -690000 USD | 9000 USD |
| 2019Q2 | -630000 USD | 9000 USD |
| 2019Q1 | -17.1 million USD | 9000 USD |
| 2018Q3 | 2.6 million USD | ? USD |
| 2018Q2 | -16.1 million USD | ? USD |
| 2018Q1 | -12.9 million USD | ? USD |
| 2017Q3 | -10.0 million USD | ? USD |
| 2017Q2 | -9.1 million USD | ? USD |
| 2017Q1 | -9.1 million USD | ? USD |
FBRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -30.5 million USD | ? USD |
| 2022 | -13.9 million USD | ? USD |
| 2021 | -21.7 million USD | ? USD |
| 2020 | -78.5 million USD | ? USD |
| 2019 | -4.1 million USD | 36000 USD |
| 2018 | -49.0 million USD | 18.0 million USD |
| 2017 | -38.9 million USD | 41000 USD |
| 2016 | -33.5 million USD | 49000 USD |
| 2015 | -23.1 million USD | 51000 USD |
FBRX
Price: $0.67
52 week price:
Earnings Per Share: -1.00 USD
P/E Ratio: -0.52
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 50864
Market Capitalization: 26.2 million